Skip to Main Content

Paper Details

Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.
Cancer Cell
2
2023
Author NameAffiliation
Michael C HaffnerFred Hutchinson Cancer Center, University of Washington, USA Division of Clinical Research
Andrea CalifanoColumbia University Irving Medical Center, USA Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons
  • 1 - 2

Datasets

Release 1.2